Undisclosed stage
Kailo Pharma raises $2.1M Undisclosed stage
$2.1M
Kailo Pharma raised $2.1M in a round1, announced Mar 22, 20261, led by NGT Healthcare II1.
Also participating: Israel Innovation Authority and Carmel (University of Haifa)1.
Lead investor
- NGT Healthcare II
Also participating
- Israel Innovation Authority
- Carmel (University of Haifa)
Sources
- 1CTech, Mar 22, 2026. “Israeli startup seeks to redefine PTSD treatment with novel brain mechanism”
How much did Kailo Pharma raise in its Undisclosed stage?
Kailo Pharma raised $2.1M in its Undisclosed stage, announced Mar 22, 2026.
Who led Kailo Pharma’s Undisclosed stage?
The round was led by NGT Healthcare II.
Which investors took part in Kailo Pharma’s Undisclosed stage?
Participants: NGT Healthcare II, Israel Innovation Authority and Carmel (University of Haifa).
How much has Kailo Pharma raised in total?
Kailo Pharma has raised $2.1M across 1 recorded round.